Zhongzhi Pharmaceutical Holdings Ltd
HKEX:3737
Zhongzhi Pharmaceutical Holdings Ltd
HKEX:3737
Price:
0.86
HKD
Market Closed
Market Cap:
HK$742.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Zhongzhi Pharmaceutical Holdings Ltd
HKEX:3737
|
CN |
|
B
|
Black Peony Group Co Ltd
SSE:600510
|
CN |
|
Easyjet PLC
LSE:EZJ
|
UK |
|
Sadhana Nitro Chem Ltd
BSE:506642
|
IN |
|
PetroChina Co Ltd
SSE:601857
|
CN |
|
H
|
Hardwyn India Ltd
NSE:HARDWYN
|
IN |
Income Statement
Earnings Waterfall
Zhongzhi Pharmaceutical Holdings Ltd
Zhongzhi Pharmaceutical Holdings Ltd
Income Statement
Zhongzhi Pharmaceutical Holdings Ltd
Zhongzhi Pharmaceutical Holdings Ltd
Currency: CNY
| Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
5
|
0
|
7
|
0
|
7
|
0
|
8
|
0
|
7
|
0
|
0
|
|
| Revenue |
730
N/A
|
803
+10%
|
945
+18%
|
1 070
+13%
|
1 142
+7%
|
1 221
+7%
|
1 342
+10%
|
1 444
+8%
|
1 604
+11%
|
1 753
+9%
|
1 747
0%
|
1 706
-2%
|
1 826
+7%
|
2 074
+14%
|
2 050
-1%
|
2 044
0%
|
2 215
+8%
|
2 007
-9%
|
1 737
-13%
|
|
| Gross Profit | ||||||||||||||||||||
| Cost of Revenue |
(331)
|
(348)
|
(380)
|
(416)
|
(434)
|
(463)
|
(507)
|
(544)
|
(613)
|
(674)
|
(682)
|
(683)
|
(756)
|
(830)
|
(829)
|
(868)
|
(930)
|
(859)
|
(792)
|
|
| Gross Profit |
399
N/A
|
455
+14%
|
564
+24%
|
654
+16%
|
708
+8%
|
758
+7%
|
835
+10%
|
900
+8%
|
991
+10%
|
1 079
+9%
|
1 064
-1%
|
1 024
-4%
|
1 070
+4%
|
1 244
+16%
|
1 221
-2%
|
1 176
-4%
|
1 285
+9%
|
1 148
-11%
|
946
-18%
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(339)
|
(384)
|
(480)
|
(567)
|
(620)
|
(648)
|
(692)
|
(743)
|
(836)
|
(934)
|
(960)
|
(902)
|
(940)
|
(1 046)
|
(1 017)
|
(1 031)
|
(1 131)
|
(1 102)
|
(926)
|
|
| Selling, General & Administrative |
(333)
|
(371)
|
(451)
|
(521)
|
(569)
|
(581)
|
(615)
|
(657)
|
(788)
|
(852)
|
(929)
|
(839)
|
(911)
|
(966)
|
(992)
|
(943)
|
(1 095)
|
(1 029)
|
(891)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
(47)
|
0
|
(50)
|
0
|
(44)
|
0
|
(46)
|
0
|
(50)
|
0
|
(57)
|
0
|
0
|
|
| Depreciation & Amortization |
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(17)
|
(34)
|
(36)
|
(3)
|
(43)
|
(3)
|
(46)
|
(4)
|
(48)
|
(3)
|
(54)
|
(3)
|
(23)
|
(4)
|
|
| Other Operating Expenses |
(6)
|
(14)
|
(29)
|
(45)
|
(50)
|
(50)
|
5
|
(50)
|
5
|
(39)
|
16
|
(16)
|
21
|
(32)
|
29
|
(33)
|
24
|
(49)
|
(32)
|
|
| Operating Income |
60
N/A
|
70
+16%
|
84
+20%
|
87
+4%
|
88
+1%
|
110
+25%
|
143
+30%
|
158
+10%
|
155
-2%
|
145
-6%
|
104
-28%
|
122
+17%
|
130
+7%
|
199
+53%
|
204
+3%
|
145
-29%
|
154
+6%
|
46
-70%
|
19
-57%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
9
|
8
|
6
|
12
|
8
|
9
|
8
|
2
|
13
|
10
|
(42)
|
(45)
|
(0)
|
3
|
3
|
(1)
|
(7)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
6
|
6
|
5
|
5
|
(0)
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
1
|
(2)
|
0
|
|
| Pre-Tax Income |
69
N/A
|
78
+13%
|
90
+15%
|
99
+11%
|
102
+2%
|
125
+23%
|
156
+25%
|
165
+6%
|
167
+1%
|
155
-7%
|
62
-60%
|
77
+25%
|
131
+70%
|
203
+55%
|
208
+2%
|
145
-30%
|
147
+1%
|
42
-71%
|
19
-55%
|
|
| Net Income | ||||||||||||||||||||
| Tax Provision |
(15)
|
(18)
|
(20)
|
(21)
|
(17)
|
(28)
|
(41)
|
(37)
|
(29)
|
(22)
|
(9)
|
(14)
|
(24)
|
(38)
|
(43)
|
(33)
|
(51)
|
(22)
|
(1)
|
|
| Income from Continuing Operations |
54
|
60
|
70
|
79
|
85
|
97
|
115
|
128
|
139
|
133
|
52
|
63
|
107
|
166
|
164
|
112
|
96
|
21
|
18
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Net Income (Common) |
54
N/A
|
60
+12%
|
70
+16%
|
79
+12%
|
85
+8%
|
97
+14%
|
115
+18%
|
128
+11%
|
139
+8%
|
133
-4%
|
52
-61%
|
63
+20%
|
106
+70%
|
164
+54%
|
163
-1%
|
111
-32%
|
95
-14%
|
21
-78%
|
17
-16%
|
|
| EPS (Diluted) |
0.07
N/A
|
0.08
+14%
|
0.09
+12%
|
0.1
+11%
|
0.1
N/A
|
0.12
+20%
|
0.14
+17%
|
0.15
+7%
|
0.17
+13%
|
0.16
-6%
|
0.06
-63%
|
0.07
+17%
|
0.13
+86%
|
0.19
+46%
|
0.19
N/A
|
0.13
-32%
|
0.11
-15%
|
0.02
-82%
|
0.02
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
